San Francisco, California
Phase 1 cancer trials in San Francisco, CA
66 Phase 1 cancer studies are recruiting participants at sites in San Francisco as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
San Francisco at a glance
- 66 studies are recruiting at a site in San Francisco.
- By phase: Early Phase 1 (4), Phase 1 (33), Phase 1/2 (29).
- By sponsor: industry (47), university, hospital or other (19).
- By research area: Prostate Cancer (16), Lung Cancer (14), Breast Cancer (13), Lymphoma (13), Melanoma (7), Pancreatic Cancer (3).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in San Francisco
Basic details from each study's public record (the 30 most recently updated of 66). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Stemline Therapeutics, Inc.
- Study site
- UCSF Helen Diller Family Comprehensive Cancer Center
- Registry record
- NCT06638307 · updated
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- ORIC Pharmaceuticals
- Study site
- University of California, San Francisco
- Registry record
- NCT05315700 · updated
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
- Phase 1/2
- Ages 18 and older
- Female participants
- Sponsor
- Hoffmann-La Roche
- Study site
- University of California, San Francisco (UCSF)
- Registry record
- NCT04802759 · updated
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genentech, Inc.
- Study site
- UCSF Helen Diller Family CCC
- Registry record
- NCT07100106 · updated
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Aminex Therapeutics, Inc.
- Study site
- University of California-San Fransisco
- Registry record
- NCT07287917 · updated
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- UCSF Medical Center - Mount Zion /ID# 257705
- Registry record
- NCT06084481 · updated
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Ensem Therapeutics
- Study site
- UCSF Helen Diller Family Comprehensive Cancer Center
- Registry record
- NCT06993844 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in San Francisco, CA on ClinicalTrials.gov.
Lung cancer studies recruiting in San Francisco
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Vivace Therapeutics, Inc
- Study site
- UCSF Helen Diller Family Comprehensive Cancer Center
- Registry record
- NCT04665206 · updated
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Institut de Recherches Internationales Servier
- Study site
- University of California, San Francisco (UCSF)
- Registry record
- NCT05786924 · updated
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Bayer
- Study site
- UCSF Helen Diller Medical Center at Parnassus Heights - Neurology
- Registry record
- NCT06914128 · updated
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Study site
- UCSF- San Francisco (Helen Diller Family Comprehensive Cancer Center)
- Registry record
- NCT07080242 · updated
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- TRIANA Biomedicines, Inc.
- Registry record
- NCT07491497 · updated
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- UCSF Helen Diller Family Comprehensive Cancer Center
- Registry record
- NCT07397338 · updated
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Tango Therapeutics, Inc.
- Study site
- University of California at San Francisco
- Registry record
- NCT06810544 · updated
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- UCSF Medical Center - Mission Bay
- Registry record
- NCT06162221 · updated
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Frontier Medicines Corporation
- Study site
- University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center
- Registry record
- NCT06244771 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in San Francisco, CA on ClinicalTrials.gov.
Prostate cancer studies recruiting in San Francisco
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- University of California
- Registry record
- NCT05997615 · updated
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Amgen
- Study site
- University of California San Francisco
- Registry record
- NCT04221542 · updated
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- University of California, San Francisco
- Study site
- University of California, San Francisco
- Registry record
- NCT07145177 · updated
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Phase 1
- Ages 18 to 100
- Male participants
- Sponsor
- Janux Therapeutics
- Study site
- UCSF Helen Diller Family Comprehensive Cancer Center
- Registry record
- NCT05519449 · updated
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- K36 Therapeutics, Inc.
- Study site
- University of California San Francisco
- Registry record
- NCT07103018 · updated
Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer
- Early Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Robert Flavell, MD, PhD
- Study site
- University of California, San Francisco
- Registry record
- NCT05851365 · updated
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- UCSF Medical Center at Mission Bay ( Site 0034)
- Registry record
- NCT06863272 · updated
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Parabilis Medicines, Inc.
- Study site
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center
- Registry record
- NCT05919264 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in San Francisco, CA on ClinicalTrials.gov.
Melanoma studies recruiting in San Francisco
A Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.
- Phase 1
- Ages 18 and older
- Female participants
- Sponsor
- Outpace Bio, Inc.
- Study site
- UCSF - Helen Diller Family Comprehensive Cancer Center
- Registry record
- NCT07664735 · updated
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Relay Therapeutics, Inc.
- Study site
- University of California, San Francisco
- Registry record
- NCT07584226 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in San Francisco, CA on ClinicalTrials.gov.
Lymphoma studies recruiting in San Francisco
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study site
- UCSF Medical Center-Mission Bay
- Registry record
- NCT04726241 · updated
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center
- Registry record
- NCT07226843 · updated
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- Phase 1
- From 24 months, up to 18 years
- All sexes
- Sponsor
- ITM Solucin GmbH
- Study site
- UCSF Benioff Children's Hospital
- Registry record
- NCT06441331 · updated
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- C. Babis Andreadis
- Study site
- University of California, San Francisco
- Registry record
- NCT04545762 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in San Francisco, CA on ClinicalTrials.gov.
Ask about studies near San Francisco
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in California
All California locations
377 studies recruiting across 44 cities.
Los Angeles
156 studies recruiting.
Duarte
109 studies recruiting.
La Jolla
37 studies recruiting.
Orange
36 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections